Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids
US6740677B2 · kind B2 · utility
3Cited by
14References
18Claims
0Family size
Inventors
Key dates
| Filing date | Aug 19, 2002 |
| Grant date | May 25, 2004 |
| Priority date | — |
| Expiry date | Aug 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for preventing or for treating benzodiazepine site (BZD-S) associated syndromes comprising administering 2′ hydroxyflavone and flavone derivatives thereof which contain a hydroxyl group at the 2′ position to a patient in need thereof in an effective dose. Methods for extracting certain of the compounds from plant material are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.